ArticleBone marrow transplantation2010
Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations.
Article in Bone marrow transplantation, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 61 citations in OpenAlex.
- Factors influencing unrelated stem cell donation a mixed-methods integrated systematic review.British journal of health psychology · 2025Pooled it
- Audits of collection and apheresis centers: guidelines by the World Marrow Donor Association Working Group Quality and Regulation.Bone marrow transplantation · 2019Guideline
- Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.Haematologica · 2019Trial
- The impact of improved JACIE standards on the care of related BM and PBSC donors.Bone marrow transplantation · 2015Trial
- Health-related quality of life of bone marrow versus peripheral blood stem cell donors: a prespecified subgroup analysis from a phase III RCT-BMTCTN protocol 0201.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2014Trial
- Trial
- Safety of hematopoietic stem cell donation from young related donors following the lowering of the age of legal adulthood in Japan.International journal of hematology · 2025Article
- Small volume bone marrow aspirates with high progenitor cell concentrations maximize cell therapy dose manufacture and substantially reduce donor hemoglobin loss.BMC medicine · 2023Article
- From Unit to Dose: A Machine Learning Approach for Precise Prediction of Hemoglobin and Iron Content in Individual Packed Red Blood Cell Units.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022Article
- Aging, Bone Marrow and Next-Generation Sequencing (NGS): Recent Advances and Future Perspectives.International journal of molecular sciences · 2021Review
- Donor assessment and follow-up: not a minor issue.Bone marrow transplantation · 2019Article
- The effect of bone marrow graft composition on pediatric bone marrow transplantation outcomes.Pediatric transplantation · 2018Article
- Related haploidentical donors are a better choice than matched unrelated donors: Counterpoint.Blood advances · 2017Article
- GMP-conformant on-site manufacturing of a CD133Stem cell research & therapy · 2017Article
- Hematopoietic Stem Cell Transplantation: A Bioethical Lens.Stem cells international · 2017Review
- Health-Related Quality of Life among Older Related Hematopoietic Stem Cell Donors (>60 Years) Is Equivalent to That of Younger Related Donors (18 to 60 Years): A Related Donor Safety Study.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2017Article
- Donor Selection for Allogenic Hemopoietic Stem Cell Transplantation: Clinical and Ethical Considerations.Stem cells international · 2017Review
- Protecting the Health and Safety of Cell and Tissue Donors.ISBT science series · 2015Article
- Use of biosimilar filgrastim compared with lenograstim in autologous haematopoietic stem-cell transplant and in sibling allogeneic transplant.Therapeutic advances in hematology · 2015Article
- The devil is in the details: confidentiality challenges in the age of genetics.HEC forum : an interdisciplinary journal on hospitals' ethical and legal issues · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 15 institutions in 11 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since the beginning of hematopoietic stem cell harvesting from volunteer unrelated donors, ensuring donor safety has been a necessary goal of all parties involved in the process. As donation of BM or PBSCs is not in the interest of the donor's own physical health, donor registries and transplantation centers must take into account both medical and ethical aspects involved in the donation procedure. One of the principal goals leading to the formation of the World Marrow Donor Association (WMDA) was to establish internationally acceptable standards for all aspects of unrelated donor care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.